Difficulty: Medium
Average Score: 66%
Practice
When providing teaching to a client starting therapy with trastuzumab, which finding should the nurse instruct the client to report?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Dyspnea. Trastuzumab is a monoclonal antibody used in the treatment of breast cancer. Dyspnea can be a sign of a serious side effect called pulmonary toxicity, which is a rare but potentially life-threatening complication of trastuzumab therapy. Therefore, it is crucial for the client to report any new or worsening respiratory symptoms promptly to their healthcare provider.
Option B) Constipation is incorrect because it is not typically associated with trastuzumab therapy. Option C) Tinnitus is also incorrect as it is not a common side effect of this medication. Option D) Dry mouth is not a priority finding to report when starting trastuzumab therapy.
From an educational perspective, it is essential for nurses to understand the common side effects and potential serious adverse reactions associated with specific medications to provide safe and effective patient care. Teaching clients to recognize and report concerning symptoms promptly can help prevent complications and improve treatment outcomes.
Option B) Constipation is incorrect because it is not typically associated with trastuzumab therapy. Option C) Tinnitus is also incorrect as it is not a common side effect of this medication. Option D) Dry mouth is not a priority finding to report when starting trastuzumab therapy.
From an educational perspective, it is essential for nurses to understand the common side effects and potential serious adverse reactions associated with specific medications to provide safe and effective patient care. Teaching clients to recognize and report concerning symptoms promptly can help prevent complications and improve treatment outcomes.